Καλάθι
Cart Icon
(0)
Καλάθι αγορών
Δεν υπάρχουν προϊόντα στο καλάθι σας.
Εναλλακτικά

The American Psychiatric Association Publishing Textbook of Psychopharmacology, 6th Edition
- 10%

The American Psychiatric Association Publishing Textbook of Psychopharmacology, 6th Edition

ISBN: 9781615374359
320,00 €
Τιμή πώλησης με έκπτωση
288,00 €
Με Φ.Π.Α.
Έκδοση
Έτος Έκδοσης
Εξώφυλλο



here rest Κατόπιν Παραγγελίας / Διαθέσιμο σε 20 - 25 ημέρες

Λεπτομέρειες

More than 160 authors—including more than 75 new contributors—lent their expertise to this sixth edition of The American Psychiatric Association Publishing Textbook of Psychopharmacology. Featuring 12 all-new chapters and fully aligned with the revised DSM-5-TR classification, this two-volume text offers an unrivaled, in-depth look at the rapidly evolving field of neuropsychopharmacology. The opening chapters provide a whirlwind tour of the multiple disciplines that undergird the chapters to come, with topics extending from the principles of molecular biology and genomics to the rudiments of neuroimaging and personalized medicine in psychiatry. The main body of the Textbook features an examination of the medication classes that form the basis of psychopharmacological treatment. For each drug within a class, data are reviewed on history and discovery, preclinical and clinical pharmacology, pharmacokinetic parameters, mechanism of action, indications and efficacy, side effects and toxicology, and drug-drug interactions. The Textbook\'s second volume focuses on psychopharmacological approaches to treatment of patients with major psychiatric disorders (e.g., mood and anxiety disorders, schizophrenia, substance use disorders) as well as patients in specific populations (e.g., adults with ADHD, pediatric patients). For each specific condition, patient population, or setting, chapters provide guidance on topics such as medication selection, combination and maintenance dosing regimens, side-effect monitoring and management, and optimization of treatment response. Closing this volume is an Appendix of Psychiatric Medications with key information on each of the agents covered in the Textbook, presented in a convenient tabular format. Noteworthy additions to this textbook include chapters addressing the following topics: • The potential roles of personalized medicine in psychiatry and of artificial intelligence and machine learning in psychopharmacology • New medications with novel pharmacological mechanisms, including the neurosteroid antidepressant brexanolone and the atypical antipsychotic pimavanserin • Use of investigational agents, such as psychedelics, in psychiatric treatment • Treatment of alcohol use disorder, PTSD, OCD, and autism spectrum disorder • Treatment of ADHD in adults • Treatment of women in all life phases, including during pregnancy and the postpartum period • Treatment of individuals with intellectual developmental disorder With a level of detail not found in any other source, this new edition of The American Psychiatric Association Publishing Textbook of Psychopharmacology illuminates the path to effective evidence-based practice of psychopharmacology for novice and seasoned clinicians alike.
Συγγραφέας
Alan F. Schatzberg, Charles B. Nemeroff
Eκδότης
American Psychiatric Association Publishing
Σελίδες
2216
el_gr
Έκδοση
Αγγλική Έκδοση
el_gr
Έτος Έκδοσης
2024
el_gr
Εξώφυλλο
Σκληρό Εξώφυλλο
Διαστάσεις
185.4 x 261.6 mm
  • Μεταφορές - Επιστροφές
  • Αρχεία

Περιγραφή Προϊόντος

More than 160 authors—including more than 75 new contributors—lent their expertise to this sixth edition of The American Psychiatric Association Publishing Textbook of Psychopharmacology. Featuring 12 all-new chapters and fully aligned with the revised DSM-5-TR classification, this two-volume text offers an unrivaled, in-depth look at the rapidly evolving field of neuropsychopharmacology. The opening chapters provide a whirlwind tour of the multiple disciplines that undergird the chapters to come, with topics extending from the principles of molecular biology and genomics to the rudiments of neuroimaging and personalized medicine in psychiatry. The main body of the Textbook features an examination of the medication classes that form the basis of psychopharmacological treatment. For each drug within a class, data are reviewed on history and discovery, preclinical and clinical pharmacology, pharmacokinetic parameters, mechanism of action, indications and efficacy, side effects and toxicology, and drug-drug interactions. The Textbook\'s second volume focuses on psychopharmacological approaches to treatment of patients with major psychiatric disorders (e.g., mood and anxiety disorders, schizophrenia, substance use disorders) as well as patients in specific populations (e.g., adults with ADHD, pediatric patients). For each specific condition, patient population, or setting, chapters provide guidance on topics such as medication selection, combination and maintenance dosing regimens, side-effect monitoring and management, and optimization of treatment response. Closing this volume is an Appendix of Psychiatric Medications with key information on each of the agents covered in the Textbook, presented in a convenient tabular format. Noteworthy additions to this textbook include chapters addressing the following topics: • The potential roles of personalized medicine in psychiatry and of artificial intelligence and machine learning in psychopharmacology • New medications with novel pharmacological mechanisms, including the neurosteroid antidepressant brexanolone and the atypical antipsychotic pimavanserin • Use of investigational agents, such as psychedelics, in psychiatric treatment • Treatment of alcohol use disorder, PTSD, OCD, and autism spectrum disorder • Treatment of ADHD in adults • Treatment of women in all life phases, including during pregnancy and the postpartum period • Treatment of individuals with intellectual developmental disorder With a level of detail not found in any other source, this new edition of The American Psychiatric Association Publishing Textbook of Psychopharmacology illuminates the path to effective evidence-based practice of psychopharmacology for novice and seasoned clinicians alike.
espa logo

test

Μεταφορές - Επιστροφές

Επιστροφές

ΠΟΛΙΤΙΚΗ ΕΠΙΣΤΡΟΦΩΝ

Στόχος μας είναι να εξασφαλίσουμε την απόλυτη ικανοποίησή σας. Αν για οποιονδήποτε λόγω, δεν μείνετε ευχαριστημένοι από την παραγγελία σας, μπορείτε να ασκήσετε το δικαίωμά σας να επιστρέψετε μέρος ή όλα τα προϊόντα που αγοράσατε εντός δεκατεσσάρων (14) ημερών από την ημερομηνία παραλαβής. Αν δεν υπάρχει διαθέσιμο

το ανάλογο προϊόν που επιθυμείτε, το ποσό διαφοράς που προκύπτει διατηρείται στον λογαριασμό σας για να το χρησιμοποιήσετε για μία άλλη αγορά. Θα γίνεται αποδεκτή μόνο η επιστροφή των προϊόντων που βρίσκονται σε άριστη κατάσταση. Παρακαλώ, σημειώστε ότι η αποστολή του μη επιθυμητού προϊόντος γίνεται με εταιρεία courier με χρέωση της εταιρίας μας. Η αποστολή του νέου προϊόντος γίνεται μέσω εταιρεία courier με χρέωση πελάτη.

ΕΛΛΑΤΩΜΑΤΙΚΟ ΠΡΟΙΟΝ

Στην περίπτωση που λάβετε ένα ελαττωματικό ή κατεστραμμένο προϊόν το βιβλιοπωλείο μας θα καταβάλλει κάθε προσπάθεια για να αντικατασταθεί με ένα ίδιο ή παρόμοιο προϊόν χωρίς κάποιο επιπλέον κόστος για σας.
Παρακαλούμε επικοινωνήστε μαζί μας με e-mail στο ipokratis@ipokratis.gr ή στο 2310212212 για περαιτέρω διευκρινήσεις.

.
espa logo

test